ERBB2 and breast cancer: Regardless of whether the intermediate p63+/Her2+ precursors differentiate into p63+/Her2− or remain p63+/Her2+, Her2 activity may play a contributory role in the pathogenesis of basal-like breast cancers originating from comedo-DCIS.